Clinical trials: Endstage Kidney Disease
Coronary Calcification, Endstage Renal Disease
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
Arterial calcification within the coronaries and other vessels is greatly accelerated among patients with chronic or end-stage kidney disease.
- Conditions
- Coronary Calcification, Endstage Renal Disease, Parathyroid Hormone
- Trial name
- NCT00502268
- Testing
- Doxercalciferol administration, Doxercalciferol administered by 1-84-7-84
- Where
- United States
- Sponsor
- Southeast Renal Research Institute
Endstage Renal Disease
Improving Adherence in Renal Dialysis Patients Through Electronic Interventions
Dialysis treatment non-adherence is a prevalent problem among the end-stage renal population receiving chronic hemodialysis. The complications associated with missed or shortened dialysis sessions are serious and frequently…
- Trial name
- NCT02970201
- Testing
- EpxDialysis
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Washington University School of Medicine
Endstage Renal Disease
Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis
End-stage renal disease (ESRD) is associated with multiple comorbidities such as cardiovascular disease, anemia, mineral and bone disorders, malnutrition, body wasting, muscle loss (sarcopenia), neurological problems and…
- Trial name
- PLAN (NCT02976688)
- Testing
- Sodium Propionate
- Volunteers
- 15 people
- Sponsor
- Azienda Sanitaria ASL Avellino 2
Endstage Renal Disease, Diabetes
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
To test the hypothesis that PPAR-gamma agonist, rosiglitazone, induces carotid plaque regression in diabetic ESRD patients on maintenance PD via its anti-inflammatory property.
- Trial name
- NCT00745914
- Testing
- Pioglitazone
- Where
- 2 sites in Hong Kong
- Volunteers
- 22 people
- Sponsor
- The University of Hong Kong
Kidney Disease
Arterial Calcifications in Nocturnal Hemodialysis and Renal Transplantation Versus Conventional Dialysis
Objective: 1. To assess whether nocturnal hemodialysis and renal transplantation are associated with less progression of coronary arterial calcification, compared with conventional hemodialysis and peritoneal dialysis; 2.
- Trial name
- NOCTX (NCT00950573)
- Where
- 2 sites in Netherlands
- Volunteers
- 184 people
- Sponsor
- Dianet Dialysis Centers
Chronic Kidney Disease, Endstage Renal Disease
Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis
This is a pilot, single-center, randomized trial of 90 subjects to evaluate complication rates and functional status decline in subjects age 65 years and older referred for vascular access placement.
- Trial name
- NCT02981706
- Testing
- Arteriovenous Fistula (AVF), Arteriovenous Graft (AVG)
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Columbia University
Endstage Renal Disease
Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism
The purpose of this study is to demonstrate an increase in protein metabolism during treatment with Physioneal 35® (containing lactate 10 mmol/l, calcium 1.75 mmol/l) compared to treatment with Physioneal 40® (containing lactate…
- Trial name
- NephropaedPD01 (NCT00776191)
- Testing
- Physioneal 35, Physioneal 40
- Where
- 5 sites in Germany
- Volunteers
- 5 people
- Sponsor
- University of Erlangen-Nürnberg Medical School
End Stage Renal Disease, Renal Failure
Homocysteine Study (HOST)
The primary objective of this study is to test the hypothesis that administration of folate, pyridoxine (vitamin B6) and cyanocobalamin (vitamin B12) in high doses to patients with advanced chronic renal failure or end stage…
- Trial name
- NCT00032435
- Testing
- PAL-40 Active
- Where
- 37 sites in United States, Puerto Rico
- Volunteers
- 2,003 people
- Sponsor
- US Department of Veterans Affairs
End-Stage Renal Disease
Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
The goal of this study is to evaluate the role of nutritional Vitamin D deficiency as a potential contributor to the morbidity witnessed in patients with end-stage renal disease
- Trial name
- NCT00677534
- Testing
- Cholecalciferol
- Volunteers
- 7 people
- Sponsor
- University of Kansas
Diabetes
Interactive Studies of Endstage Diabetic Dialysis Patients
The purpose of this study is to document relevant and related clinical changes associated with different hemoglobin concentrations in diabetic hemodialysis patients.
- Trial name
- NCT00175734
- Testing
- High Hemoglobin Concentration, Low Hemoglobin Concentration
- Where
- Canada
- Volunteers
- 80 people
- Sponsor
- University of British Columbia
Hyperphosphatemia, Inflammation
An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients
The purpose of the study is to determine whether an ingestion of a new renal multivitamin supplement can have a beneficial effect on bone and mineral adn inflammation issues related to patients on dialysis.
- Conditions
- Hyperphosphatemia, Inflammation, Renal Disease
- Trial name
- NCT00834301
- Testing
- Oral Multivitamin
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Nephrian
Kidney Failure, Chronic
Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients
Diabetes after kidney transplantation is a frequent complication, the incidence of which varies from 7 to 45% depending on the studies and on the diagnostic criteria used.
- Trial name
- GLITTER (NCT03640026)
- Testing
- Tacrolimus
- Where
- 2 sites in France
- Volunteers
- 61 people
- Sponsor
- Centre Hospitalier Departemental Vendee